Clinical Trial Update: Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of adalimumab in patients with psoriasis and obstructive sleep apnea; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea
• Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Psoriasis, Sleep Apnea, Obstructive | Phase 4 | Status: COMPLETED